top of page
viIMMUNE is an emerging biopharmaceutical company dedicated to the discovery and commercialization of innovative antiviral drugs. As a clinical stage company, exploits small molecules as inhibitors of different enzymes in pathogenic viruses life cycle. Our mission at viIMMUNE is to help alleviate human suffering by discovering long-acting antiviral therapeutics through innovative approaches.
-
To develop potent long-acting antiviral agents against HIV and SARS-CoV-2
-
To develop multifunctional antiviral agents that display broad- spectrum activity
-
To commercialize drugs with enhanced antiviral activity
-
especially against multi-drug resistant virus
-
cell-associated virus
-
targeting hidden virus reservoirs
-
bottom of page